Medline ® Abstract for Reference 75

of 'Treatment of relapsing-remitting multiple sclerosis in adults'

75
 
 
U.S. Food and Drug Administration. FDA approves new multiple sclerosis treatment: Tecfidera. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345528.htm (Accessed on April 10, 2013).
 
no abstract available